Insider Stock Trading History of Rosenberg Martin


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Rosenberg Martin since year 2005. The trader's CIK number is 1320122. At the time of this reporting, Rosenberg Martin is the Director of Cubist Pharmaceuticals Inc . (stock ticker symbol CBST). See this page for all insider trading activities at Cubist Pharmaceuticals Inc .


Stock purchases, sales, and option exercises reported by insider Rosenberg Martin since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-09-09 CBST Cubist Pharmaceuticals Inc Option Ex 15,472 23.81 368,388
2013-09-09 CBST Cubist Pharmaceuticals Inc Sale 15,472 65.00 1,005,680
2013-06-06 CBST Cubist Pharmaceuticals Inc Option Ex 1,347 .00 0
2012-10-01 CBST Cubist Pharmaceuticals Inc Option Ex 10,000 22.71 227,100
2012-10-01 CBST Cubist Pharmaceuticals Inc Sale 10,000 47.75 477,480
2012-07-02 CBST Cubist Pharmaceuticals Inc Sale 10,000 37.88 378,760
2012-07-02 CBST Cubist Pharmaceuticals Inc Option Ex 10,000 22.30 222,950
2012-04-02 CBST Cubist Pharmaceuticals Inc Option Ex 10,000 .00 0
2012-04-02 CBST Cubist Pharmaceuticals Inc Sale 10,000 42.76 427,600
2012-01-03 CBST Cubist Pharmaceuticals Inc Option Ex 10,000 20.05 200,500
2012-01-03 CBST Cubist Pharmaceuticals Inc Sale 10,000 40.08 400,820
2011-12-15 CBST Cubist Pharmaceuticals Inc Option Ex 11,500 18.22 209,530
2011-12-15 CBST Cubist Pharmaceuticals Inc Sale 11,500 37.10 426,661
2009-03-30 CBST Cubist Pharmaceuticals Inc Option Ex 2,000 9.56 19,120
2008-07-22 CBST Cubist Pharmaceuticals Inc Sale 10,000 22.00 220,000
2008-07-22 CBST Cubist Pharmaceuticals Inc Option Ex 10,000 10.02 100,200

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Rosenberg Martin (Director of Cubist Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.